Germany
Japan
United Kingdom
China
Antibodies
Clone OTI4C5, Anti-DDK (FLAG) monoclonal antibody, Biotin
| Applications | FC, IF, WB |
| Conjugation | Biotin |
ADFP (PLIN2) (5-27) mouse monoclonal antibody, clone AP125, Purified
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Rat |
GFP (Ads. to Hu, Ms, Rt Serum Proteins) goat polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, WB |
| Immunogen | Green Fluorescent Protein (GFP) fusion protein corresponding to the full length amino acid sequence (246 aa) derived from the jellyfish Aequorea victoria |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
pan Cytokeratin guinea pig polyclonal antibody, Serum
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | Synthetic peptides of Human Keratins. |
Fibroblasts (Pan Reticular) rat monoclonal antibody, clone ER-TR7, Purified
| Applications | FC, IF, IHC |
| Reactivities | Human, Mouse |
Goat Polyclonal Anti-UIS4 Antibody
| Applications | IF |
| Reactivities | Plasmodium berghei |
| Immunogen | Purified recombinant peptide produced in E. coli. |
IGHG4 mouse monoclonal antibody, clone HP6025, AP, Purified
| Applications | ELISA: 1/1000-1/2000 (2-9). Immunohistochemistry on Frozen Sections: reported in literature (5,7,10,11). Immunohistochemistry on Paraffin Sections: reported in literature (10). Flow Cytometry: reported in literature (15, 18, 19). Immunocytochemistry: reported in literature (12). Western Blot: reported in literature (3,13-16). |
| Reactivities | Human |
| Conjugation | AP |
USD 250.00
2 Weeks
USD 415.00
2 Weeks
Adeno-associated Virus / AAV (VP1 + VP2 + VP3) mouse monoclonal antibody, clone B1, Purified
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Monkey |
USD 475.00
2 Weeks
Mouse monoclonal tGFP antibody (clone OTI2H8), DyLight 594 conjugated
| Applications | IF |
| Conjugation | DyLight 594 |
EPCAM mouse monoclonal antibody, clone HEA125, FITC
| Applications | IF, IHC |
| Reactivities | Human |
| Conjugation | FITC |
USD 450.00
2 Weeks
Human IgA mouse monoclonal antibody, clone NI 69 (A89-034) and NI 184 (A89-035), Ascites
| Applications | To identify the presence of IgA in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as Radioimmunoassay, ELISA, Indirect Immunoperoxidase and Immunofluorescence staining of cytoplasmic IgA, Haemagglutination and Immunoblotting. General Recommended Dilutions: Histochemical Use: 1/50-1/200. ELISA: from 1/500 upwards. Western blot: from 1/1000 upwards. |
| Reactivities | Human |
USD 260.00
2 Weeks
gamma Tubulin (TUBG1) (434-449) mouse monoclonal antibody, clone TU-32, Aff - Purified
| Applications | ELISA, IF, WB |
| Reactivities | Mammalian, Plant |
Tyrosine Hydroxylase (TH) mouse monoclonal antibody, clone LNC1
| Applications | IF, IHC, WB |
| Reactivities | All Species |
| Conjugation | Unconjugated |
Symetric Dimethylarginine (SDMA) rabbit polyclonal antibody, Serum
| Applications | ELISA, IF, IHC, R, WB |
| Immunogen | Symmetric Dimethylarginine (SDMA) KLH-conjugated. |
VIP rabbit polyclonal antibody
| Applications | IF, IHC |
| Reactivities | Mammalian |
| Conjugation | Unconjugated |
| Immunogen | Porcine VIP coupled to bovine thyroglobulin (BTg) with carbodiimide (CDI) linker. |
USD 415.00
2 Weeks
Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified
| Applications | ELISA, FN, IF, IHC, IP |
| Reactivities | Human, Monkey |
Lipoteichoic Acid (LTA) mouse monoclonal antibody, clone 55, Low Endotoxin
| Applications | ELISA, IF, IHC, WB |
Candida albicans rabbit polyclonal antibody, Purified
| Applications | ELISA, ID, Ie, IF, IHC |
| Reactivities | Candida |
| Immunogen | Candida albicans, type A (ATTCC #32354). |
Active filters
Category
Applications
- IF
Filter by
Target Symbol
- MAP2K1 (207)
- PDCD1 (137)
- MAP2K3 (134)
- CTAG1B (131)
- TP53 (111)
- LIPG (107)
- KLK8 (106)
- ERCC1 (97)
- MAPK13 (89)
- CDKN2A (87)
- ERBB2 (86)
- L1CAM (85)
- VIM (84)
- PNMT (82)
- MDM4 (75)
- PECAM1 (70)
- SQSTM1 (65)
- APP (64)
- CTNNB1 (64)
- LOX (64)
- AKT1 (61)
- GFAP (61)
- IDO1 (61)
- MLANA (61)
- BSG (60)
- PTPRE (60)
- EPCAM (59)
- MYC (59)
- NPR3 (58)
- PSMC3 (57)
- ACAT2 (56)
- CD163 (56)
- MIOX (56)
- PDE4A (56)
- SENP2 (56)
- BUB1B (55)
- CCT8L2 (55)
- CD19 (55)
- MAPK7 (55)
- MCL1 (55)
- MOB3B (55)
- MTRF1L (55)
- NME4 (55)
- CHGA (54)
- IGF2BP2 (54)
- CDK2 (53)
- MAPRE2 (53)
- SYP (52)
- TACC3 (52)
- UBE2G2 (52)
- BTK (51)
- LIMK1 (51)
- RNF144B (51)
- BECN1 (50)
- BTN1A1 (50)
- FAHD2A (50)
- LENG1 (50)
- PGAM2 (50)
- PIK3AP1 (50)
- SMS (50)
- SPG7 (50)
- VWA5A (50)
- CD80 (48)
- KRT7 (48)
- SNAP25 (48)
- CCM2 (47)
- ERG (47)
- SOCS3 (47)
- TH (47)
- GBP2 (46)
- HIBCH (46)
- SNX9 (46)
- ALDH1L1 (45)
- ARHGAP25 (45)
- CD1C (45)
- ELK3 (45)
- FOXI1 (45)
- HOXC11 (45)
- PARVA (45)
- PIK3R5 (45)
- TAL1 (45)
- ERCC4 (44)
- AFP (43)
- POR (43)
- SAMHD1 (43)
- ATP5F1B (42)
- PRKAR2A (42)
- PYCR2 (42)
- ACAA2 (41)
- CRYAB (41)
- DTYMK (41)
- HDAC6 (41)
- RASSF1 (41)
- ARFGAP1 (40)
- CD33 (40)
- DYNC1LI1 (40)
- LRATD2 (40)
- MICAL1 (40)
- MMP13 (40)
- NHEJ1 (40)
Reactivities
- Human (25092)
- Mouse (17057)
- Rat (15565)
- Monkey (2726)
- Dog (2316)
- Bovine (404)
- Chicken (157)
- Pig (139)
- Rhesus Monkey (101)
- Xenopus (100)
- Canine (82)
- Zebrafish (82)
- Hamster (79)
- Primate (71)
- Porcine (62)
- Rabbit (61)
- X. tropicalis (58)
- Chimpanzee (45)
- Sheep (42)
- Cow (34)
- Feline (32)
- Mammalian (29)
- Drosophila (20)
- Guinea Pig (19)
- C. elegans (16)
- Goat (13)
- Avian (9)
- SARS-CoV (9)
- SARS-CoV-2 (7)
- Equine (6)
- Fish (6)
- Broad (5)
- Yeast (3)
- All Species (2)
- Beluga (2)
- Carp (2)
- Coral (2)
- Dengue virus (2)
- Fusion proteins containing the Flag Tag (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Birds (1)
- Chlamydomonas (1)
- Dogfish (1)
- Drosophila melanogaster (1)
- Frog (1)
- Fungus (1)
- Hagfish (1)
- Horse (1)
- Invertebrate (1)
- Medaka fish (1)
- Mink (1)
- Mustelid (1)
- Orang-Utan (1)
- Quail (1)
- SimianIVE (1)
- Staphylococcus aureus (1)
- Streptococcus Pyogenes (1)
- Tobacco (1)
- Tomato (1)
Antibody Hosts
Isotypes
- IgG1 (12835)
- IgG (8481)
- IgG2a (4092)
- IgG2b (3322)
- Ig (239)
- IgG3 (147)
- IgG1, kappa (129)
- IgG, kappa (123)
- IgM (115)
- IgG2a, kappa (46)
- IgY (41)
- IgG2b, kappa (20)
- Fab fragment, kappa (16)
- IgG2 (11)
- IgM, kappa (11)
- IgG1, lambda (5)
- IgG3, kappa (4)
- cocktail (3)
- IgA (2)
- IgG1/IgG2a (2)
- IgG2, kappa (2)
- IgG2a, lambda (2)
- F(ab)2, kappa (1)
- IgG1/IgK (1)
- IgG2b, lambda (1)
- IgG4 (1)
Clonalities
Conjugates
- Unconjugated (19316)
- Biotin (3463)
- HRP (3213)
- FITC (332)
- PE (73)
- TRITC (52)
- Alexa Fluor 546 (47)
- Alexa Fluor 488 (44)
- Alexa Fluor 647 (17)
- His Tag (17)
- Texas Red (16)
- APC (9)
- Cy5 (8)
- AP (4)
- PE-Cy7 (3)
- APC-Cy5.5 (2)
- DyLight 488 (2)
- DyLight 594 (2)
- PE-Cy5.5 (2)
- PerCP (2)
- Rhodamine (2)
- APC-Cy7 (1)
- BIMA (1)
- DTAF (1)
- DyLight 550 (1)
- PerCP-Cy5.5 (1)
Knockout (KO) Validation
Modifications
- Unmodified (2518)
- Phospho-specific (145)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (32)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (14)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (4)
- Acetyl K5 (3)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (3)
- Acetyl K12 (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- TriMethyl K56 (2)
- Acetyl K14 (1)
- Acetyl K15 (1)
- Acetyl K16 (1)
- Acetyl K18 (1)
- Acetyl K23 (1)
- Acetyl K27 (1)
- Acetyl K29 (1)
- Acetyl K36 (1)
- Acetyl K4 (1)
- Acetyl K56 (1)
- Acetyl K8 (1)
- Acetyl K9 (1)
- Acetyl K9/K14/K18/K23/K27 (1)
- Acetyl K91 (1)
- Asymmetric DiMethyl R3 (1)
- MonoMethyl K36 (1)
- MonoMethyl K5 (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- Pan DiMethyl-lysine (1)
- Pan Phospho-Tyrosine (1)
- Phospho S10 (1)
- Phospho S10/T11 (1)
- Phospho S2056 (1)
- Phospho S241 (1)
- Phospho S2448 (1)
- Phospho S28 (1)
- Phospho S428 (1)
- Phospho S465/467 + S423/425 (1)
- Phospho S519/T522 (1)
- Phospho S70 (1)
- Phospho S9 (1)
- Phospho Ser404 (1)
- Phospho Ser416 (1)
- Phospho T11 (1)
- Phospho T180/Y182 (1)
- Phospho T202/Y204 + T185/Y187 (1)
- Phospho T389 (1)
- Phospho T395 (1)
- Phospho T45 (1)
- Phospho T498 (1)
- Phospho T6 (1)
- Phospho T91 (1)
- Phospho Y1022/1023 (1)
- Phospho Y15 (1)
- Phospho Y705 (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column. (1)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- Unconjugated (1)
- citrulline R2/R8/R17 (1)
Assay Types
Families
- Druggable Genome (13632)
- Transmembrane (4542)
- Transcription Factors (3017)
- Protein Kinase (2001)
- ES Cell Differentiation/IPS (1801)
- Secreted Protein (1632)
- Stem cell - Pluripotency (898)
- Protease (805)
- Adult stem cells (328)
- GPCR (280)
- Phosphatase (243)
- Embryonic stem cells (217)
- P450 (193)
- Stem cell relevant signaling - JAK/STAT signaling pathway (161)
- Induced pluripotent stem cells (138)
- Ion Channels: Other (137)
- Cancer stem cells (131)
- Nuclear Hormone Receptor (119)
- Stem cell relevant signaling - DSL/Notch pathway (118)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (75)
- Ion Channels: Potassium (47)
- Stem cell relevant signaling - Wnt Signaling pathway (40)
- Ion Channels: Glutamate Receptors (21)
- Ion Channels: Transient receptor potential (18)
- Ion Channels: ATP Receptors (5)
- Ion Channels: Cyclic nucleotide gated (4)
- Ion Channels: Cys-loop Receptors (4)
- Ion Channels: Calcium (3)
- Ion Channels: Sodium (1)
Pathways
- Metabolic pathways (2569)
- Pathways in cancer (1903)
- MAPK signaling pathway (1415)
- Focal adhesion (1091)
- Neurotrophin signaling pathway (1043)
- Prostate cancer (1000)
- Toll-like receptor signaling pathway (927)
- Pancreatic cancer (921)
- Chronic myeloid leukemia (900)
- T cell receptor signaling pathway (892)
- Progesterone-mediated oocyte maturation (885)
- Colorectal cancer (870)
- Non-small cell lung cancer (866)
- Insulin signaling pathway (863)
- ErbB signaling pathway (857)
- Fc epsilon RI signaling pathway (854)
- Endometrial cancer (839)
- Regulation of actin cytoskeleton (838)
- Melanoma (835)
- Glioma (794)
- Bladder cancer (769)
- GnRH signaling pathway (720)
- B cell receptor signaling pathway (692)
- Fc gamma R-mediated phagocytosis (685)
- Acute myeloid leukemia (681)
- Chemokine signaling pathway (672)
- Cell cycle (665)
- VEGF signaling pathway (638)
- Renal cell carcinoma (628)
- Gap junction (623)
- Apoptosis (593)
- Cell adhesion molecules (CAMs) (585)
- Thyroid cancer (560)
- Natural killer cell mediated cytotoxicity (556)
- Leukocyte transendothelial migration (548)
- Small cell lung cancer (511)
- Oocyte meiosis (509)
- p53 signaling pathway (509)
- Amyotrophic lateral sclerosis (ALS) (498)
- Jak-STAT signaling pathway (478)
- Alzheimer's disease (461)
- Wnt signaling pathway (454)
- Huntington's disease (447)
- Purine metabolism (439)
- Endocytosis (437)
- Melanogenesis (425)
- Hematopoietic cell lineage (396)
- Adherens junction (388)
- Axon guidance (383)
- Vascular smooth muscle contraction (380)
- Long-term potentiation (370)
- Cytokine-cytokine receptor interaction (365)
- Long-term depression (362)
- Prion diseases (353)
- Ubiquitin mediated proteolysis (342)
- Tight junction (340)
- Type II diabetes mellitus (335)
- Adipocytokine signaling pathway (329)
- mTOR signaling pathway (327)
- Parkinson's disease (325)
- Pathogenic Escherichia coli infection (323)
- Epithelial cell signaling in Helicobacter pylori infection (304)
- Glycolysis / Gluconeogenesis (295)
- Calcium signaling pathway (278)
- Neuroactive ligand-receptor interaction (278)
- NOD-like receptor signaling pathway (275)
- Systemic lupus erythematosus (275)
- Dorso-ventral axis formation (273)
- RIG-I-like receptor signaling pathway (262)
- Pyrimidine metabolism (259)
- Primary immunodeficiency (257)
- Valine (247)
- TGF-beta signaling pathway (244)
- Basal cell carcinoma (240)
- leucine and isoleucine degradation (231)
- Nucleotide excision repair (208)
- Arginine and proline metabolism (207)
- Glycerolipid metabolism (198)
- Oxidative phosphorylation (195)
- Tyrosine metabolism (189)
- Tryptophan metabolism (188)
- Antigen processing and presentation (173)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (173)
- Viral myocarditis (171)
- Pyruvate metabolism (170)
- Drug metabolism - cytochrome P450 (162)
- Metabolism of xenobiotics by cytochrome P450 (157)
- Arachidonic acid metabolism (153)
- Proteasome (152)
- Fatty acid metabolism (144)
- Type I diabetes mellitus (139)
- Propanoate metabolism (138)
- beta-Alanine metabolism (134)
- PPAR signaling pathway (128)
- Regulation of autophagy (127)
- Citrate cycle (TCA cycle) (126)
- Glutathione metabolism (126)
- Hypertrophic cardiomyopathy (HCM) (126)
- Butanoate metabolism (125)
- Graft-versus-host disease (124)
- Phosphatidylinositol signaling system (124)
- Cytosolic DNA-sensing pathway (123)
- Inositol phosphate metabolism (120)
- Olfactory transduction (119)
- Glycine (117)
- serine and threonine metabolism (117)
- Fructose and mannose metabolism (115)
- Dilated cardiomyopathy (113)
- Retinol metabolism (113)
- Maturity onset diabetes of the young (112)
- Cysteine and methionine metabolism (108)
- Vibrio cholerae infection (106)
- Notch signaling pathway (105)
- Base excision repair (102)
- ECM-receptor interaction (102)
- Lysine degradation (97)
- Complement and coagulation cascades (95)
- Pentose phosphate pathway (94)
- Linoleic acid metabolism (93)
- Lysosome (92)
- Terpenoid backbone biosynthesis (92)
- Amino sugar and nucleotide sugar metabolism (91)
- Spliceosome (89)
- RNA degradation (85)
- Cardiac muscle contraction (80)
- Hedgehog signaling pathway (80)
- Allograft rejection (79)
- Mismatch repair (74)
- Synthesis and degradation of ketone bodies (72)
- Autoimmune thyroid disease (71)
- Ascorbate and aldarate metabolism (65)
- DNA replication (65)
- Non-homologous end-joining (63)
- One carbon pool by folate (62)
- Homologous recombination (60)
- Galactose metabolism (59)
- Drug metabolism - other enzymes (57)
- Histidine metabolism (57)
- Caffeine metabolism (56)
- Starch and sucrose metabolism (56)
- RNA polymerase (55)
- SNARE interactions in vesicular transport (54)
- Nicotinate and nicotinamide metabolism (49)
- Alanine (48)
- aspartate and glutamate metabolism (48)
- N-Glycan biosynthesis (45)
- Folate biosynthesis (42)
- Fatty acid elongation in mitochondria (41)
- Renin-angiotensin system (40)
- Sphingolipid metabolism (38)
- Porphyrin and chlorophyll metabolism (36)
- Biosynthesis of unsaturated fatty acids (34)
- Glyoxylate and dicarboxylate metabolism (34)
- Nitrogen metabolism (34)
- Glycosaminoglycan degradation (33)
- Other glycan degradation (30)
- Glycerophospholipid metabolism (29)
- Circadian rhythm - mammal (27)
- Primary bile acid biosynthesis (26)
- Sulfur metabolism (26)
- Ribosome (25)
- Basal transcription factors (24)
- Pantothenate and CoA biosynthesis (24)
- Androgen and estrogen metabolism (22)
- Selenoamino acid metabolism (21)
- Asthma (19)
- Methane metabolism (19)
- Glycosphingolipid biosynthesis - lacto and neolacto series (17)
- Keratan sulfate biosynthesis (17)
- Glycosphingolipid biosynthesis - ganglio series (16)
- Phenylalanine metabolism (16)
- Vitamin B6 metabolism (16)
- leucine and isoleucine biosynthesis (16)
- Taurine and hypotaurine metabolism (14)
- Fatty acid biosynthesis (13)
- Aminoacyl-tRNA biosynthesis (12)
- Limonene and pinene degradation (12)
- Taste transduction (11)
- Steroid biosynthesis (10)
- ABC transporters (8)
- O-Glycan biosynthesis (7)
- Pentose and glucuronate interconversions (7)
- Riboflavin metabolism (7)
- C21-Steroid hormone metabolism (6)
- Heparan sulfate biosynthesis (5)
- Chondroitin sulfate biosynthesis (4)
- D-Glutamine and D-glutamate metabolism (4)
- Ether lipid metabolism (2)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (2)
- alpha-Linolenic acid metabolism (2)
- Glycosphingolipid biosynthesis - globo series (1)
- O-Mannosyl glycan biosynthesis (1)
- Protein export (1)